Skip to main content
BioGaia logo

BioGaia — Investor Relations & Filings

Ticker · BIOG ISIN · SE0017769995 LEI · 549300UBUJOY2L7TT361 ST Manufacturing
Filings indexed 610 across all filing types
Latest filing 2026-05-07 Regulatory Filings
Country SE Sweden
Listing ST BIOG

About BioGaia

https://www.biogaia.com/

BioGaia is a healthcare and biotechnology company that is a world leader in probiotics. A pioneer in microbiome research for over 30 years, the company develops, markets, and sells a range of clinically proven probiotic products. Its portfolio is centered on its patented probiotic strain, Lactobacillus reuteri. These products, typically offered as food supplements, are designed to support the health and well-being of consumers at all stages of life.

Recent filings

Filing Released Lang Actions
Bulletin from Annual General Meeting of BioGaia AB (publ)
Regulatory Filings
2026-05-07 English
Kommuniké från årsstämma i BioGaia
Regulatory Filings
2026-05-07 English
Quarterly Report 2026
Quarterly Report
2026-05-07 English
Quarterly Report 2026
Quarterly Report
2026-05-07 English
Notice to attend the Annual General Meeting of BioGaia AB (publ)
AGM Information Classification · 94% confidence The document is a press release titled “Notice to attend the Annual General Meeting of BioGaia AB (publ)”. It provides the date, time, location, instructions for participation, proxy details, proposed agenda items, and resolutions to be voted on at the AGM. This clearly corresponds to materials shared in connection with an upcoming Annual General Meeting rather than the full annual report or any other filing. Therefore, it should be classified as AGM Information.
2026-03-30 English
Kallelse till årsstämma i BioGaia AB (publ)
Proxy Solicitation & Information Statement Classification · 91% confidence The document is a comprehensive Notice (kallelse) of an Annual General Meeting for BioGaia, detailing the meeting date, eligibility, proxy rules, full agenda, board and nomination committee proposals, dividend proposals, and incentive program proposals. These are materials sent to shareholders in advance to solicit their attendance and votes prior to the AGM. This clearly aligns with the Proxy Solicitation & Information Statement category (PSI). It is not simply an announcement of a report publication, nor a detailed investor presentation or earnings release, but the formal meeting notice and proxy information.
2026-03-30 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.